Author Archives: Warren Woessner

Anticipat Discusses Success in Overturning Abstract Idea Rejections on Appeal

Posted on December 15, 2017 by Warren Woessner

For difficult grounds of rejection, the right advocacy can make all the difference. The right counsel can know when to appeal and how to win on appeal. Here, we explore the demographic of firms that represent appellants that overturn one … Continue reading →

Posted in Patent Eligible Subject Matter | Leave a comment

PTAB Changes Begin To Help Inventors

Posted on December 12, 2017 by Warren Woessner

This is a guest post from Russ Slifer and was originally posted on Law360. The past year has seen significant changes to all practice areas before the U.S. Patent Trial and Appeal Board. Many of these changes are positive for patent owners, … Continue reading →

Posted in Inter Partes Review | Leave a comment

Ex Parte Patterson: Assay Based on Two “Natural Phenomena” Does Not Equal One “Inventive Concept”

Posted on December 8, 2017 by Warren Woessner

According to the “Mayo/Alice” rule, if a claim is directed to a “natural phenomena” such as the relationship between the a drug’s metabolite concentration following administration of an immunosuppressive drug and the therapeutic window of efficacy of the drug, the claim … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged Alice, CIN, Mayo, Patterson | Leave a comment

“An Unusual Case” – Promega Corp. v. Life Technologies Corp.

Posted on December 4, 2017 by Warren Woessner

I am going to try to summarize the Fed. Cir.’s holding and reasoning in Promega Corp. v. Life Tech Corp., Appeal No. 2013-1011 et al. (Fed. Cir., November 13, 2017), without burying you in the procedural details, but it won’t … Continue reading →